Edinburgh BioQuarter, GSK Partner for Pancreatitis R&D
BioWorld International Correspondent
LONDON – The new Edinburgh BioQuarter made the first step toward its aim of becoming Scotland's translational research hub, signing a drug discovery collaboration with GlaxoSmithKline plc in acute pancreatitis.
The deal follows a trawl by GSK as it hunts for 10 projects for its recently established university collaboration scheme, the Academic Discovery Performance Unit.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter